Alexander-Miller MA - Search Results

1

Potential therapeutic action of nitrite in sickle cell disease.

Wajih N, Basu S, Jailwala A, Kim HW, Ostrowski D, Perlegas A, Bolden CA, Buechler NL, Gladwin MT, Caudell DL, Rahbar E, Alexander-Miller MA, Vachharajani V, Kim-Shapiro DB. Wajih N, et al. Redox Biol. 2017 Aug;12:1026-1039. doi: 10.1016/j.redox.2017.05.006. Epub 2017 May 10. Redox Biol. 2017. PMID: 28511346 Free PMC article.

2

Sirtuin1 Targeting Reverses Innate and Adaptive Immune Tolerance in Septic Mice.

Martin AN, Alexander-Miller M, Yoza BK, Vachharajani V, McCall CE. Martin AN, et al. J Immunol Res. 2018 Jul 4;2018:2402593. doi: 10.1155/2018/2402593. eCollection 2018. J Immunol Res. 2018. PMID: 30069485 Free PMC article.

3

Paramyxovirus activation and inhibition of innate immune responses.

Parks GD, Alexander-Miller MA. Parks GD, et al. J Mol Biol. 2013 Dec 13;425(24):4872-92. doi: 10.1016/j.jmb.2013.09.015. Epub 2013 Sep 20. J Mol Biol. 2013. PMID: 24056173 Free PMC article. Review.

4

In vivo activation of leukocyte GPR120/FFAR4 by PUFAs has minimal impact on atherosclerosis in LDL receptor knockout mice.

Shewale SV, Brown AL, Bi X, Boudyguina E, Sawyer JK, Alexander-Miller MA, Parks JS. Shewale SV, et al. J Lipid Res. 2017 Jan;58(1):236-246. doi: 10.1194/jlr.M072769. Epub 2016 Nov 3. J Lipid Res. 2017. PMID: 27811230 Free PMC article.

5

Neuroinflammation after Intracerebral Hemorrhage and Potential Therapeutic Targets.

Tschoe C, Bushnell CD, Duncan PW, Alexander-Miller MA, Wolfe SQ. Tschoe C, et al. J Stroke. 2020 Jan;22(1):29-46. doi: 10.5853/jos.2019.02236. Epub 2020 Jan 31. J Stroke. 2020. PMID: 32027790 Free PMC article. Review.

6

Targeting the CD47/thrombospondin-1 signaling axis regulates immune cell bioenergetics in the tumor microenvironment to potentiate antitumor immune response.

Stirling ER, Terabe M, Wilson AS, Kooshki M, Yamaleyeva LM, Alexander-Miller MA, Zhang W, Miller LD, Triozzi PL, Soto-Pantoja DR. Stirling ER, et al. Among authors: alexander miller ma. J Immunother Cancer. 2022 Nov;10(11):e004712. doi: 10.1136/jitc-2022-004712. J Immunother Cancer. 2022. PMID: 36418073 Free PMC article.

7

Cutting edge: CD8+ T cell clones possess the potential to differentiate into both high- and low-avidity effector cells.

Kroger CJ, Alexander-Miller MA. Kroger CJ, et al. J Immunol. 2007 Jul 15;179(2):748-51. doi: 10.4049/jimmunol.179.2.748. J Immunol. 2007. PMID: 17617563

8

Pivotal Advance: Nonfunctional lung effectors exhibit decreased calcium mobilization associated with reduced expression of ORAI1.

Arimilli S, Sharma SK, Yammani R, Reid SD, Parks GD, Alexander-Miller MA. Arimilli S, et al. J Leukoc Biol. 2010 Jun;87(6):977-88. doi: 10.1189/jlb.0809575. Epub 2010 Jan 26. J Leukoc Biol. 2010. PMID: 20103768 Free PMC article.

9

CD4+ T cell subset differentiation and avidity setpoint are dictated by the interplay of cytokine and antigen mediated signals.

Shiner EK, Holbrook BC, Alexander-Miller MA. Shiner EK, et al. PLoS One. 2014 Jun 18;9(6):e100175. doi: 10.1371/journal.pone.0100175. eCollection 2014. PLoS One. 2014. PMID: 24940899 Free PMC article.

10

A Novel R848-Conjugated Inactivated Influenza Virus Vaccine Is Efficacious and Safe in a Neonate Nonhuman Primate Model.

Holbrook BC, Kim JR, Blevins LK, Jorgensen MJ, Kock ND, D'Agostino RB Jr, Aycock ST, Hadimani MB, King SB, Parks GD, Alexander-Miller MA. Holbrook BC, et al. J Immunol. 2016 Jul 15;197(2):555-64. doi: 10.4049/jimmunol.1600497. Epub 2016 Jun 8. J Immunol. 2016. PMID: 27279374 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

96 results

Search Page

Filters